Results 271 to 280 of about 46,891 (297)

Emerging potential of cannabidiol in reversing proteinopathies

Ageing Research Reviews, 2021
Raju Dash, Md Chayan Ali, Israt Jahan
exaly  

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2018
Elizabeth A Thiele, Eric D Marsh, Jacqueline A French   +2 more
exaly  

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

New England Journal of Medicine, 2018
Orrin Devinsky, Vicente E Villanueva, Elaine C Wirrell   +2 more
exaly  

Cannabidiol safety

2021
Andrew Charrette, James Akingbasote, Najla Guthrie, Corey J. Hilmas   +3 more
openaire   +1 more source

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Translational Psychiatry, 2012
F Markus Leweke
exaly  

Cannabidiol, neuroprotection and neuropsychiatric disorders

Pharmacological Research, 2016
Manoela V Fogaça
exaly  

Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

Redox Biology, 2020
Martin Garrido-Rodriguez, Marco A Calzado, Laureano de la Vega   +2 more
exaly  

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

Journal of Psychopharmacology, 2013
Amir Englund, Judith Fay Nottage, Amanda Feilding   +2 more
exaly  

Labeling Accuracy of Cannabidiol Extracts Sold Online

JAMA - Journal of the American Medical Association, 2017
Marcel O Bonn-Miller, Ryan Vandrey
exaly  

Naturheilmittel Cannabidiol?

2019
Hintergrund: Seit geraumer Zeit wird Cannabidiol (CBD), ein Inhaltsstoff der Hanfpflanze, als neues Heilmittel aus der Natur diskutiert. Im Gegensatz zu Tetrahydrocannabinol (THC) wirkt CBD nicht psychoaktiv. Ihm werden jedoch eine Vielzahl an anderen Auswirkungen auf den Organismus zugesprochen, da er zusammen mit dem körpereigenen Endocannabinoid ...
openaire   +1 more source